Romosozumab was not effective in preventing multiple spontaneous clinical vertebral fractures after denosumab discontinuation: A case report

Discontinuation of denosumab is associated with the increase of bone turnover markers to above-baseline levels (so-called rebound in bone turnover) and rapid bone loss. Several studies have reported vertebral fractures (VFs), particularly multiple spontaneous clinical VFs (MSCVFs), occurring after d...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Masafumi Kashii, Kosuke Ebina, Kazuma Kitaguchi, Hideki Yoshikawa
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2020-12-01
Schriftenreihe:	Bone Reports
Schlagworte:	Denosumab Romosozumab Vertebral fractures Discontinuation
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S2352187220300486
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!